Home
Browse All Titles
Sign In
Browse All Titles
Pharmacy Practice and the Law
About
Table of Contents
Main Index
Case Studies
Search
GoogleAnalytics
All Resources
Current Resource
Go
i
https://webview.skyscape.com:11002?IndexTerms-page=17
◀
*
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
Y
Z
▶
View All
Stuart (1956)
People v. Stuart
State Authority to Regulate
(1999)
Duty to Warn Under the Learned Intermediary Doctrine
Promoting Prescription Drugs and Devices Through Social Media
per se rule
per se violations, types of
Shalala (1998)
Importance of the Orange Book in Generic Substitution
Pfizer, Inc. v. Shalala
pharmaceutical care model
pharmaceutical equivalents
Food and Drug Administration (1980)
Explanation of the Durham-Humphrey Amendment
Patient Package Inserts
Pharmaceutical Manufacturers Association v. Food and Drug Administration
Pharmaceutical Research and Manufacturers of America (PhRMA)
Prescription Drug Advertising: Manufacturer to Professionals
The Patient Safety and Quality Improvement Act of 2005
pharmacies, licensing of
Pharmacist's Guide to Prescription Fraud
Pharmacist's Manual (2010)
pharmacist care
pharmacist-in-charge (PIC)
pharmacists
absence of
and product liability
definition
disciplinary actions, overview
drug information website
impaired pharmacist programs
licensing overview
malpractice insurance
pharmacist-in-charge (PIC)
Pharmacists and Product Liability
reinstatement of revoked licenses
risk management role
strict liability and
pharmacy advertising
pharmacy and therapeutics (PandT) committee
pharmacy compounding
Compliance Policy Guide 1992
Compliance Policy Guide 2002
draft compliance guides
Drug Quality and Security Act of 2013 (DQSA)
new drug issue
other issues
patent issues
Pharmacy Compounding vs Manufacturing
USP compounding requirements
vs. manufacturing
pharmacy inspections
constitutional requirements
DEA inspections under CSA
Pharmacy Inspections
practical considerations
state pharmacy board inspections
clinical judgment exercises
clinical trials
application for registration
informed consent
investigational drugs, access to
Investigational New Drug (IND) application
registration requirements
Clozaril Patient Management System
See consumer medication information (CMI)
Approved Drugs for Off-Label (Unlabeled) Indications
Prescription Drug Labeling Information for the Patient
See consumer medication information (CMI)
Useful Written Patient Information and Medication Guides
CMS
Code of Federal Regulations (CFR)
Cohen v. Missouri Board of Pharmacy (1998)
collaborative practice agreements
collection, DEA definition
collector, DEA definition
Colonnade Catering v. United States (1970)
Refresh
first
prev
...
11
12
13
14
15
16
17
18
19
20
...
30
select
next
last
Displaying items 481 - 510 of 1113